Kerklaan B J, van Berckel B N M, Herholz K, Dols A, van der Flier W M, Scheltens P, Pijnenburg Y A L
Alzheimer Center VU Medical Center, Amsterdam, The Netherlands Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands Department of Neurology, Zaans Medical Center, Zaandam, The Netherlands
Department of Nuclear Medicine, VU Medical Center, Amsterdam, The Netherlands.
Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):607-13. doi: 10.1177/1533317514524811. Epub 2014 Feb 26.
Characteristic frontotemporal abnormalities on structural or functional neuroimaging are mandatory for a diagnosis of probable behavioral variant of frontotemporal dementia (bvFTD) according to the new criteria. 18-Fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) imaging is commonly reserved for patients with suspected bvFTD without characteristic structural neuroimaging results. We studied the diagnostic value of 18F-FDG-PET in these patients.
The 18F-FDG-PET was performed in 52 patients with suspected bvFTD but lacking characteristic structural neuroimaging results. The clinical diagnosis of bvFTD in the presence of functional decline (bvFTD/fd+) after a follow-up period of 2 years was used as a golden standard.
The sensitivity of 18F-FDG-PET for bvFTD/fd+ was 47% at a specificity of 92%. The differential diagnosis comprised alternative neurodegenerative and psychiatric disorders and a benign phenocopy of bvFTD.
The 18F-FDG-PET is able to identify nearly half of the patients with bvFTD who remain undetected by magnetic resonance imaging. In our selected group, high specificity enables exclusion of psychiatric and other neurodegenerative disorders.
根据新的标准,结构或功能神经影像学上典型的额颞叶异常对于可能的行为变异型额颞叶痴呆(bvFTD)的诊断是必不可少的。18氟脱氧葡萄糖正电子发射断层扫描(18F-FDG-PET)成像通常用于疑似bvFTD但没有典型结构神经影像学结果的患者。我们研究了18F-FDG-PET在这些患者中的诊断价值。
对52例疑似bvFTD但缺乏典型结构神经影像学结果的患者进行了18F-FDG-PET检查。以随访2年后出现功能衰退(bvFTD/fd+)时bvFTD的临床诊断作为金标准。
18F-FDG-PET对bvFTD/fd+的敏感性为47%,特异性为92%。鉴别诊断包括其他神经退行性疾病和精神疾病以及bvFTD的良性拟表型。
18F-FDG-PET能够识别近一半磁共振成像未检测出的bvFTD患者。在我们选定的组中,高特异性能够排除精神疾病和其他神经退行性疾病。